| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Guangdong Taienkang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.71 |
| 52 Week High | CN¥20.50 |
| 52 Week Low | CN¥11.65 |
| Beta | -0.12 |
| 11 Month Change | 11.65% |
| 3 Month Change | 1.93% |
| 1 Year Change | -19.64% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -29.37% |
Recent News & Updates
Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Taienkang Pharmaceutical (SZSE:301263)
Sep 03
Guangdong Taienkang Pharmaceutical Co., Ltd.'s (SZSE:301263) P/E Still Appears To Be Reasonable
Aug 23Here's Why Guangdong Taienkang Pharmaceutical (SZSE:301263) Can Manage Its Debt Responsibly
Jul 22Recent updates
Weak Statutory Earnings May Not Tell The Whole Story For Guangdong Taienkang Pharmaceutical (SZSE:301263)
Sep 03Guangdong Taienkang Pharmaceutical Co., Ltd.'s (SZSE:301263) P/E Still Appears To Be Reasonable
Aug 23Here's Why Guangdong Taienkang Pharmaceutical (SZSE:301263) Can Manage Its Debt Responsibly
Jul 22Guangdong Taienkang Pharmaceutical (SZSE:301263) Is Paying Out Less In Dividends Than Last Year
May 22Guangdong Taienkang Pharmaceutical (SZSE:301263) Seems To Use Debt Quite Sensibly
Feb 26Shareholder Returns
| 301263 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.9% | 1.6% | 2.7% |
| 1Y | -19.6% | 0.7% | 4.6% |
Return vs Industry: 301263 underperformed the CN Pharmaceuticals industry which returned 0.7% over the past year.
Return vs Market: 301263 underperformed the CN Market which returned 4.6% over the past year.
Price Volatility
| 301263 volatility | |
|---|---|
| 301263 Average Weekly Movement | 6.9% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 7.6% |
| 10% most volatile stocks in CN Market | 11.5% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 301263 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301263's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 931 | Hanjie Zheng | www.tai-kang.com.cn |
Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company provides products covering various therapeutic areas, including gender health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the forms of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as an agent for pharmaceutical products; and offers medical and daily cotton swabs, masks, sutures, surgical staplers, vascular clips and clip appliers, etc., as well as non-prescription drugs.
Guangdong Taienkang Pharmaceutical Co., Ltd. Fundamentals Summary
| 301263 fundamental statistics | |
|---|---|
| Market cap | CN¥5.81b |
| Earnings (TTM) | CN¥136.90m |
| Revenue (TTM) | CN¥751.12m |
42.4x
P/E Ratio7.7x
P/S RatioIs 301263 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301263 income statement (TTM) | |
|---|---|
| Revenue | CN¥751.12m |
| Cost of Revenue | CN¥309.06m |
| Gross Profit | CN¥442.07m |
| Other Expenses | CN¥305.17m |
| Earnings | CN¥136.90m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 29, 2024
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 58.85% |
| Net Profit Margin | 18.23% |
| Debt/Equity Ratio | 16.0% |
How did 301263 perform over the long term?
See historical performance and comparison